Patients should be aware of warning signs and seek medical advice if severe or unusual symptoms develop during treatment
A plateau is worth discussing with a doctor if: your weight has not changed for several weeks despite consistent medication use you have troublesome side effects you are skipping meals because you feel too full or nauseated you have symptoms of dehydration you are losing weight too quickly you feel weak, dizzy or faint you have diabetes and your glucose readings are changing your mood has worsened you are planning pregnancy, pregnant or breastfeeding you use oral contraception and are taking tirzepatide you have upcoming surgery, endoscopy, colonoscopy or another procedure requiring anaesthesia or sedation you are considering changing dose, restarting after a break, or switching medication you are buying products online and are unsure whether they are legitimate The TGA has updated advice for tirzepatide and oral contraceptives: patients using oral hormonal contraception are advised to switch to a non-oral method or add a barrier method for 4 weeks after starting tirzepatide and for 4 weeks after each dose escalation
Clinical trials have shown that semaglutide can lead to significant weight loss, making it an attractive option for individuals struggling to shed excess pounds
59% chance
For example: In a 1998 study published in the European Journal of Endocrinology , researchers found that ipamorelin stimulated the release of growth hormone in rats and pigs without raising cortisol (also known as the stress hormone), which other peptides are known to do
DDR1, Discoidin domain receptor 1
:quality(75):max_bytes(102400)/https://assets.iprofesional.com/assets/jpg/2025/12/608599.jpg)
